No abstract available.
Gastritis*

No abstract available.
Gastritis*

No abstract available.
Gastritis*

Author used Weiati 999 to treat 60 patients with chronic gastritis. The results have shown that 81.2% of treated patients did not have upper abdominal pain and the other symptoms also disappeared in 61.6% to 87.1% of patients. Endoscopically, 71,7% of treated patients had not gastric mucosal inflammation after treatment. The good effect on the activity of inflammation appeared in 75.4%. The ratio of HP eradication is 34.5%. It should note that the effects of Weitai 999 in patients with HP (-) is better than these in patients with HP (+). The effects in patients with atrophic gastritis, intestinal metaplasia and dysplasia is not statistical significance.
Gastritis ; therapeutics

No abstract available
Gastritis* ; Stomach*

No abstract available
Endosonography* ; Gastritis*

The opening, comparing results before and after treatment clinical trial was performed to abserve the effects of Weitai 999 (an oriental medicine imported from China) on 60 patients with chronic gastritis, were treated by 500 mg of Weitai 999, 4 tablets a day for 30 days. The results showed that 81.2% of patients did not have upper abdominal pain. Endoscopy showed 71.7% of patients had not gastric mucosal inflammation after treatment. Histopathology showed good effect on activity of inflammation in 75.4% of patients. The rate of HP eradication was 34.5%. There was not clinical side effects
gastritis ; Therapeutics ; Pharmaceutical Preparations

103 patients were diagnosed as chronic gastritis by gastro endoscopy with biopsy and histological examination (using the visual analogue scale of the Revised Sydney classification) and blood test for H.pylori antibody IgG. The result shown that: the rate of H.pylori in atrophic gastritis was higher than that in non atrophic gastritis (67% and 8.7%, respectively, p<0.01). The HP rate among active chronic gastritis (moderate and severe) also was higher than mild group (p<0.001). The rate of atrophic chronic gastritis was 79.6%; of non atrophic chronic gastritis was 21.4%. Atrophic chronic gastritis in antrum accounted for 73.8%, in antrum and corpus 5.8%, intestinal metaplasia 8.2%, dysplasia 4.1%
Gastritis, Atrophic ; Helicobacter pylori

The study was conducted on 69 patients with Helicobacter pylori-related chronic gastritis that was confirmed by endoscopy, histopathological findings, urease test and culture. The severity of HP-related chronic gastritis and the HP infectivity of body and antrum of stomach followed and the relationship between severity of chronic gastritis and HP infectivity was determined. The results showed that all patients had inflammatous lesions in body and antrum. The HP incidence and infectivity were both higher in body than in antrum. The activity of inflammation and the severity of chronic inflammation in body and antrum increased positively with the HP infectivity.
gastritis ; Helicobacter pylori ; diagnosis

The histopathological tests of 70 patients have shown that the rate of killing of H. pylori of outlines AS and BS were 51.51% and 59.56%, respectively. Both outlines had an anti-inflammatory effect and interruption of the inflammatory action with the rates of AS and BS were 42.42% and 51.35%, respectively, or reduced the inflammatory action level, concurrently recovered the level of the chronic inflammatory. The treatment of above two outlines found not influence clearly on the intestinal dysphasia and heteroplasia.
gastritis ; Helicobacter pylori ; therapeutics